WL276 CAR-T Cell Therapy

· Beijing Immunochina Medical Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WL276 CAR-T Cell Therapy, covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients [EARLY_Phase 1]